https://www.marketscreener.com/quote/stock/NEWRON-PHARMACEUTICALS-S--198001/news/Newron-to-Evaluate-Burden-of-Disease-for-Rett-Syndrome-Patients-and-Families-22579387/?utm_source=telegram&utm_medium=social&utm_campaign=share